Huber Showcases New Temperature Control Solutions at Achema 2018
Pharmaceutical Technology's In the Lab eNewsletter
Huber Kältemaschinenbau presents new temperature control solutions for research, laboratories, and production in Frankfurt.
At Achema 2018, Huber will be showcasing new solutions and further developments in temperature control from -125 °C to +425 °C for research laboratories and process industry. Huber’s product range on display include Unistats, Unichillers, and classic bath circulators, as well as specialized equipment and ATEX solutions.
The Unistat series of temperature control systems are suited for applications in process engineering and offer a continuous scale-up through research, kilo lab, mini plant, pilot plant, and production.
Huber will also present two new thermoelectric chillers with Peltier technology named Piccolo. The compact devices are suitable for heating and cooling of external applications in the laboratory. In addition, a new Unichiller with carbon dioxide as refrigerant are shown as well as various laboratory bestsellers such as the Ministats and Minichiller.
Other highlights include environmentally friendly cooling units with natural refrigerants as well as software solutions for process development and Industry 4.0.
Source: Huber, Hall B49, Booth 4.2
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
